CDx Diagnostics is a company providing tools that help to preempt cancer through the detection of precancerous cellular changes. It offers a diagnostic platform that synthesizes computer imaging, artificial intelligence, molecular biology and three-dimensional cytopathology to detect precancerous change. The company develops WATS3D, a tool used for the detection of Barrett’s esophagus and dysplasia.